Remove Conditions Remove Information Remove Therapy
article thumbnail

Study: Cannabis Safe and Effective in Fibromyalgia Patients

NORML

Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.” ” Patients were most likely to report overall reductions in pain and overall improvements in their quality of life following cannabis therapy.

Patients 279
article thumbnail

Nevada: Governor Signs Medical Cannabis Expansion Measure

NORML

Steve Sisolak has signed legislation, Senate Bill 430 , expanding the pool of patients eligible for medical cannabis therapy. The measure allows patients diagnosed with anxiety disorders, autism, chronic pain, opioid dependency, and other conditions to obtain a recommendation for medical cannabis. ’

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Cannabis Associated with Reduced Opioid Use, Prolonged Benefits in Pain Patients

NORML

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.

Patients 356
article thumbnail

CDC Still Soliciting Comments Regarding Chronic Pain Management Solutions

NORML

According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5 If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display.”

article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. With clinical research developing rapidly in Israel and with the use of innovative technology we hope to have this information in the near future.

article thumbnail

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

They concluded : “The addition of dronabinol resulted in reduced opioid consumption, … suggesting a beneficial opioid-sparing effect of dronabinol in acutely painful conditions. Additional information on the relationship between cannabis and opioids is available in the NORML fact-sheet here.

article thumbnail

North Dakota: Governor Signs Medical Cannabis Expansion Laws

NORML

House Bill 1519 significantly expands the pool of patients eligible for medical cannabis therapy to include those diagnosed with autism spectrum disorder, migraine, anorexia, and Tourette Syndrome, among other debilitating conditions. For more information on pending state legislation, visit NORML’s Take Action Center here.

Law 208